Quantcast

Latest Inflammatory bowel disease Stories

2014-05-21 23:08:04

ReportsnReports.com adds “Crohn’s Disease Drug Market and Pipeline Analysis” report to its research store. Dallas, Texas (PRWEB) May 21, 2014 Under the umbrella of inflammatory bowel diseases, Crohn’s disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn’s disease in most cases affects the end of the small bowel (the ileum)...

2014-05-15 16:27:54

NEW YORK, May, 15, 2014 /PRNewswire-USNewswire/ -- In an effort to increase their long-standing commitment of improving the lives of those with inflammatory bowel disease (IBD), the Crohn's & Colitis Foundation of America (CCFA) will host the first U.S. IBD2020 meeting from May 16(th)- May 18(th) in New Orleans, LA. http://photos.prnewswire.com/prnvar/20140515/88144 "IBD2020 USA is a critical meeting of some of the brightest minds who are thinking about both IBD and Quality of...

2014-05-13 23:10:01

New Findings for EnteraGam™ (Serum-derived bovine immunoglobulin/protein isolate, SBI) Cary, NC (PRWEB) May 13, 2014 Abigail Henderson, PhD, presented new preclinical data for the prescription medical food, EnteraGam™ (serum-derived bovine immunoglobulin/protein isolate, SBI), demonstrating that the immunoglobulin-based protein mixture in SBI binds and neutralizes two types of toxins (exotoxins A and B) from several ribotypes of C. difficile, including recently isolated strains with...

2014-05-13 00:21:38

- This Is First Study to Demonstrate Clinical Benefit of Oral alpha 4 Integrin Antagonist in Patient with Inflammatory Bowel Disease - TOKYO, May 13, 2014 /PRNewswire/ -- Ajinomoto Pharmaceuticals Co., Ltd. (President, Takashi Nagamachi; Headquarters, Tokyo, Japan) announced on May 13 that the Phase 2a results of an oral alpha 4 integrin antagonist, AJM300, in patients with ulcerative colitis were presented in the Joint Presidential Plenary Session at Digestive Disease Week (DDW)...

2014-05-08 12:30:08

Two new gifts will benefit faculty in stem cell science and digestive diseases LOS ANGELES, May 8, 2014 /PRNewswire-USNewswire/ -- Two new gifts from The Eli and Edythe Broad Foundation to UCLA totaling $4 million will fund research in stem cell science and digestive diseases and support the recruitment of key faculty at two renowned research centers. The gifts bring to $30 million The Broad Foundation's total support of faculty recruitment and basic and translational research at...

2014-05-05 08:28:29

Academic and Industry Teams Converge to Focus on Inflammatory Bowel Disease and Advance Innovative Interception and Prevention Strategies SPRING HOUSE, Pa., May 5, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the establishment of a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC), Prometheus Laboratories Inc. (Prometheus), Mayo Clinic, Rochester, Minnesota (Mayo Clinic), Centre Hospitalier Regional...

2014-05-01 12:31:32

Sephure® ensures proper placement of suppositories, improves patient quality of life and compliance CONCORD, Mass., May 1, 2014 /PRNewswire/ -- Jennifer Davagian Ensign, Founder & CEO of Cristcot Inc. today announced that Sephure®, a first-of-its-kind disposable suppository applicator, is now available to the millions of people who require suppository medication therapy. Although billions of suppositories are sold around the world each year, there is no standard of care for...

2014-04-30 16:30:12

Afternoon to Honor Robbyn Sockolow, MD; Hosted by Veteran TV News Anchor Liz Cho and featuring a Fashion Presentation by Bergdorf Goodman NEW YORK, April 30, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA), Greater New York Chapter, will host their Twenty-First Annual Women of Distinction Luncheon at the Waldorf-Astoria on Thursday, May 1(st). The luncheon will be hosted by veteran WABC-TV News Anchor, Liz Cho. To purchase tickets to the 21(st) Annual...

2014-04-30 10:21:24

May provide therapeutic target for treating inflammatory bowel disease and preventing colitis-associated colorectal cancer, according to new research published in the American Journal of Pathology The adhesion molecule CD146 plays a vital role in inflammation and offers a promising therapeutic target for treating inflammatory bowel disease (IBD) as well as preventing colitis-associated colorectal cancer, say scientists. Targeting CD146 with anti-CD146 antibody AA98, especially in...

2014-04-23 08:31:08

Ten scholarships of up to $5,000 now available, up from seven last year TORONTO, April 23, 2014 /CNW/ - Crohn's and Colitis Canada and AbbVie are providing funding for more students living with Crohn's disease and ulcerative colitis through an increased number of AbbVie IBD scholarships. There are now ten (10) one-time scholarships of up to $5,000 CAN available (up from 7 in 2013) to meet the increasing need for support of Canadian students living with these chronic diseases....


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related